Home » Topics » BioWorld Science

BioWorld Science
RSS

Universita degli Studi di Siena discovers new antivirals

Oct. 4, 2019

Black Diamond Therapeutics describes preclinical activity of mutant EGFR/HER2 inhibitor BDTX-189

Oct. 4, 2019

Phase I safety and PK data presented for novel CXCR4 antagonist YF-H-2015005

Oct. 4, 2019

TERT gene fusions as novel biomarkers in metastatic Leydig cell tumors

Oct. 4, 2019

AL-008 potentiates the antitumor effector functions of macrophages and dendritic cells

Oct. 4, 2019

FDA approves Entresto for pediatric heart failure

Oct. 4, 2019

Allogene Therapeutics initiates phase I study of ALLO-715

Oct. 4, 2019

Targeting ATP6V1A subunit in the v-ATPase complex inhibits mTORC1 signaling and activates autophagy

Oct. 4, 2019

Phase II data show efficacy of TTP-399 as an adjunctive therapy for type 1 diabetes

Oct. 3, 2019

Actinogen reports cognition data on Xanamem in healthy elderly subjects

Oct. 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...